Cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) genes at chromosomal arm 9p21 are frequently altered in patients with acute lymphoblastic leukemia (ALL) [22]. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.